Literature DB >> 22686483

Role of α5β1 and αvβ3 integrins in relation to adhesion and spreading dynamics of prostate cancer cells interacting with fibronectin under in vitro conditions.

Anna Stachurska1, Jerzy Elbanowski, Hanna M Kowalczyńska.   

Abstract

Interaction of cell integrins with the ECM (extracellular matrix) proteins is commonly assumed to be associated with cell dissemination and tumour metastases. Since these processes depend on the mechanism of cell-protein interaction, we have attempted to show the contribution of α5β1 and αvβ3 integrins of the prostate cancer PC-3 cells in in vitro interaction with FN (fibronectin) adsorbed on defined polystyrene surfaces. Cell adhesion, spreading and cytoskeleton organization were studied using antibodies against integrins or a GRGDSP (Gly-Arg-Gly-Asp-Ser-Pro) peptide. The results show that blocking the α5β1 integrin causes: (i) a decrease in the number of the adherent cells in the early phase of adhesion and (ii) a decrease in the dynamics of cell spreading and cell shape changes, and weaker reorganization of cytoskeletal proteins than in the control cells. Conversely, the blocking of the αvβ3 integrin: (i) causes no observable effect on the number of the adhered cells; however, (ii) causes an increase in the dynamics of cell spreading and cell shape changes, and stronger reorganization of cytoskeletal proteins than in the control cells. Interestingly, the blocking of integrins with a GRGDSP peptide strongly decreases the number of the adhered cells, and a complete inhibition of cell spreading. Our results strongly suggest that the α5β1 integrin plays the main role in the adhesion and spreading of PC-3 cells interacting with FN, whereas the αvβ3 integrin seems to regulate other receptors in the spreading process. Moreover, integrin-FN interaction through the RGD sequence evidently curbed the cell adhesion and spreading.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22686483     DOI: 10.1042/CBI20110522

Source DB:  PubMed          Journal:  Cell Biol Int        ISSN: 1065-6995            Impact factor:   3.612


  13 in total

1.  Hsa-miR-370 inhibited P-selectin-induced cell adhesion in human colon adenocarcinoma cells.

Authors:  Yunhai Wei; Jie Shao; Yan Wang; Hua Shen; Sheng Yu; Jinyu Zhang; Lei Yin
Journal:  Mol Cell Biochem       Date:  2018-06-19       Impact factor: 3.396

2.  Biomimetic Hydrogels Incorporating Polymeric Cell-Adhesive Peptide To Promote the 3D Assembly of Tumoroids.

Authors:  Ying Hao; Aidan B Zerdoum; Alexander J Stuffer; Ayyappan K Rajasekaran; Xinqiao Jia
Journal:  Biomacromolecules       Date:  2016-10-20       Impact factor: 6.988

3.  S100A9 promotes prostate cancer cell invasion by activating TLR4/NF-κB/integrin β1/FAK signaling.

Authors:  Zhonghua Lv; Wenlin Li; Xichao Wei
Journal:  Onco Targets Ther       Date:  2020-07-03       Impact factor: 4.147

4.  The tumor suppressor gene ARHI (DIRAS3) inhibits ovarian cancer cell migration through multiple mechanisms.

Authors:  Zhen Lu; Robert C Bast
Journal:  Cell Adh Migr       Date:  2013-01-28       Impact factor: 3.405

5.  Silibinin inhibits fibronectin induced motility, invasiveness and survival in human prostate carcinoma PC3 cells via targeting integrin signaling.

Authors:  Gagan Deep; Rahul Kumar; Anil K Jain; Chapla Agarwal; Rajesh Agarwal
Journal:  Mutat Res       Date:  2014-10       Impact factor: 2.433

6.  Metastasis of cholangiocarcinoma is promoted by extended high-mannose glycans.

Authors:  Diane Dayoung Park; Chatchai Phoomak; Gege Xu; Laura P Olney; Khiem A Tran; Simon S Park; Nathan E Haigh; Guillaume Luxardi; Worachart Lert-Itthiporn; Michiko Shimoda; Qiongyu Li; Nobuyuki Matoba; Fernando Fierro; Sopit Wongkham; Emanual Maverakis; Carlito B Lebrilla
Journal:  Proc Natl Acad Sci U S A       Date:  2020-03-25       Impact factor: 11.205

7.  Talin1 phosphorylation activates β1 integrins: a novel mechanism to promote prostate cancer bone metastasis.

Authors:  J-K Jin; P-C Tien; C-J Cheng; J H Song; C Huang; S-H Lin; G E Gallick
Journal:  Oncogene       Date:  2014-05-05       Impact factor: 9.867

Review 8.  Targeted nonviral gene therapy in prostate cancer.

Authors:  Najla Altwaijry; Sukrut Somani; Christine Dufès
Journal:  Int J Nanomedicine       Date:  2018-09-25

Review 9.  The functional role of integrins during intra- and extravasation within the metastatic cascade.

Authors:  Greta Sökeland; Udo Schumacher
Journal:  Mol Cancer       Date:  2019-01-18       Impact factor: 27.401

10.  RGD-Binding Integrins in Prostate Cancer: Expression Patterns and Therapeutic Prospects against Bone Metastasis.

Authors:  Mark Sutherland; Andrew Gordon; Steven D Shnyder; Laurence H Patterson; Helen M Sheldrake
Journal:  Cancers (Basel)       Date:  2012-10-26       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.